Summary
Leukotrienes are synthesised from arachidonic acid via the 5-lipoxygenase pathway in neutrophils, eosinophils, monocytes/macrophages, basophils and certain mast cell populations. Their synthesis is closely regulated by several known factors and the cells which contain 5-lipoxygenase do not all possess the capability to synthesise all of the leukotrienes. Neutrophils produce leukotriene B4, which attracts other neutrophils, whereas the leukotriene C4, produced by eosinophils, increases the contractile activity of smooth muscle. Monocytes/macrophages are able to produce both of these leukotrienes. Receptor sites for leukotriene B4 have been identified on monocytes and neutrophils and receptors for leukotriene D4, a cleavage product of leukotriene C4, have been defined in pulmonary tissue.
In animals, sulphidopeptide leukotrienes have been shown to cause potent vasoconstriction resulting in increased blood pressure and increased vascular permeability leading to hypovolaemia. These leukotrienes also depress renal (in animals) and pulmonary (in animals and humans) function, the latter probably as a result of effects on peripheral rather than central airways. In patients with mild asthma, however, there is no differential activity of this type. The sulphidopeptide leukotrienes caused wheal and flare when administered intradermally in healthy volunteers, which was of considerably longer duration than that induced by prostaglandin D2. Conversely, leukotriene B4 caused accumulation of neutrophils in the absence of wheal and flare.
Studies into the effects of dietary fish oil showed that 2 constituents, docosahexanoic acid and eicosapentaenoic acid (EPA), inhibit the conversion of arachidonic acid by cyclo-oxygenase, but not by 5-lipoxygenase. Furthermore, 5-lipoxygenase converts EPA to a pentene series of leukotrienes and the sulphidopeptide derivatives possess similar activity to their tetrameric counterparts. Conversely, the pentene leukotriene B5 has attenuated activity. In healthy volunteers, it was shown that the 5-lipoxygenase pathway was markedly attenuated in activated white blood cells after 6 weeks of dietary supplementation with fish oil capsules. In addition, the neutrophils had lost their ability to adhere to endothelial cell monolayers and demonstrated a reduced capacity to engage in a chemotactic response.
The leukotrienes, therefore, are important factors in mediating inflammation and the potential for moderating their activity by dietary means deserves a full clinical examination.
Similar content being viewed by others
References
Badr KF, Baylis JM, Pfeffer JM, Pfeffer MA, Soberman RJ, et al. Renal and systemic hemodynamic responses to intravenous infusion of leukotriene C4 in the rat. Circulation Research 54: 492, 1984
Borgeat P, Samuelsson B. Transformation of arachidonic acid by rabbit polymorphonuclear leukocytes. Formation of a novel dihydroxy-eicosatetraenoic acid. Journal of Biological Chemistry 254: 2643, 1979
Drazen JM, Austen KF. Effects of intravenous administration of slow-reacting substance of anaphylaxis, histamine, bradykinin and prostaglandin F2α on pulmonary mechanics in the guinea pig. Journal of Clinical Investigation 53: 1679–1685, 1974
Drazen JM, Austen KF. Leukotrienes and airway responses. American Review Respiratory Disease, in press, 1987
Drazen JM, Lewis RA, Wasserman SI, Orange RP, Austen KF. Differential effects of a partially purified preparation of slow-reacting substance of anaphylaxis (SRS-A) on guinea pig tracheal spirals and parenchymal strips. Journal of Clinical Investigation 6: 1–5, 1979
Drazen JM, Austen KF, Lewis RA, Clark DA, Goto G, et al. Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. Proceedings of the National Academy of Sciences USA 77: 4354–4358, 1980
Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis. Lancet 2: 117, 1978
Fischer S, Schacky CV, Siess W, Strasser Th, Weber PC. Uptake, release and metabolism of docosahexaenoic acid (DHA, C22:6ω3) in human platelets and neutrophils. Biochemical and Biophysical Research Communications 120: 907–918, 1982
Goldman DW, Goetzl EJ. Specific binding of leukotriene B4 to receptors on human polymorphonuclear leukocytes. Journal of Immunology 129: 1600, 1982
Goldyne, ME. Heterogeneity in leukocyte preparations: effects on defining eicosanoid metabolism by human lymphocytes and monocytes. Journal of Allergy and Clinical Immunology 74 (Suppl.): 331–337, 1984
Griffin M, Weiss JW, Leitch AG, McFadden Jr ER, Corey EJ, et al. Effects of leukotriene D on the airways in asthma. New England Journal of Medicine 308: 436–439, 1983
Hamel R, Masson P, Ford-Hutchinson AW, Jones TR, Brunet G, Piechuta H. Differing mechanisms for leukotriene D4-induced bronchoconstriction in guinea pigs following intravenous aerosol administration. Prostaglandins 24: 419–432, 1982
Holroyde MC, Altounyan REC, Cole M, Dixon M, Elliot EV. Bronchoconstriction produced in man by leukotriene C and D. Lancet 2: 17–19, 1981
Jakschik BA, Falkenhein S, Parker CW. Precursor role of arachidonic acid in slow reacting substance release from rat basophilic leukemia cells. Proceedings of the National Academy of Sciences (USA) 74: 4577, 1977
Lee TH, Austen KF. Arachidonic acid metabolism by the 5-lipoxygenase pathway, and the effects of alternative dietary fatty acids. Advances in Immunology 39: 145, 1986
Lee CW, Lewis RA, Tauber AI, Mehrotra MM, Corey EJ, et al. The myeloperoxidase-dependent metabolism of leukotriene C4, D4, and E4 to 6-trans-leukotriene B4 diastereoisomers and the subclass specific S-diastereoisomeric sulfoxides. Journal of Biological Chemistry 258: 15004, 1983
Lee TH, Mencia-Huerta J-M, Shih C, Corey EJ, Lewis RA, Austen KF. Effects of exogenous arachidonic,eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. Journal of Clinical Investigation 74: 1922–1933, 1984
Lee TH, Hoover RL, Williams JD, Sperling RI, Ravalese J, et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. New England Journal of Medicine 312: 1217–1224, 1985
Leitch AG, Austen KF, Corey EJ, Drazen JM. Effects of indomethacin on guinea pig pulmonary response to intravenous leukotrienes C4 and D4. Clinical Science 65: 281, 1983
Levine L, Morgan RA, Lewis RA, Austen KF, Clark D, et al. Radioimmunoassay of the leukotrienes of slow reacting substance of anaphylaxis. Proceedings of the National Academy of Sciences (USA) 78: 7692, 1981
Lewis RA, Austen KF. Molecular determinants for functional responses to the sulfidopeptide leukotrienes: metabolism and receptor subclasses. Journal of Allergy and Clinical Immunology 74 (Suppl.): 369–372, 1984
Michoud MC, Pare PD, Orange RP, Hogg JC. Airway sensitivity to slow-reacting substance of anaphylaxis,histamine and antigen in Ascaris sensitive monkeys. American Review of Respiratory Diseases 119: 419–424, 1979
Mong S, Wu HL, Scott MO, Lewis MA, Clark MA, et al. Molecular heterogeneity of leukotriene receptors: correlation of smooth muscle contraction and radioligand binding in guinea pig lung. Journal of Pharmacology and Experimental Therapeutics 234: 316, 1985
Murphy RC, Hammarström B, Samuelsson B, Leukotriene C, a slow reacting substance from murine mastocytoma cells. Proceedings of the National Academy of Sciences USA 76: 4275, 1979
Murphy RC, Pickett WC, Culp BR, Lands WEM. Tetraene and pentaene leukotrienes: selective production from murine mastocytoma cells after dietary manipulation. Prostaglandins 22: 613–622, 1981
Owen WE, Soberman RJ, Yoshimoto T, Sheffer AL, Lewis RA, et al. Synthesis and release of leukotriene C4 by human eosinophils. Journal of Immunology, in press, 1987
Silberstein DS, Owen F, Gasson JC, Di Persio JF, Golde DW, et al. Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor. Journal of Immunology 137: 3290, 1986
Soter NA, Lewis RA, Corey EJ, Austen KF. Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin. Journal of Investigative Dermatology 80: 115–119, 1983
Sperling RI, Weinblatt M, Robin J-L, Coblyn J, Fraser P, et al. Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis. Arthritis & Rheumatism 29: 41, 1986
Sun FF, Chau L-Y, Spur B, Corey EJ, Lewis RA,et al. Identification of a high affinity LTC4-binding protein in rat liver cytosol as glutathione-S-transferase. Journal of Biological Chemistry 261: 8540, 1986
Weiss JW, Drazen JM, Coles N, McFadden Jr ER, Weller PF, et al. Bronchoconstrictor effects of leukotriene C in humans. Science 216: 196–198, 1982a
Weiss JW, Drazen JM, McFadden Jr ER, Weller P, Corey EJ,et al. Comparative bronchoconstrictor effects of histamine,leukotriene C and leukotriene D in normal human volunteers. Transactions of the Association of American Physicians 95: 30–35, 1982b
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Austen, K.F. The Role of Arachidonic Acid Metabolites in Local and Systemic Inflammatory Processes. Drugs 33 (Suppl 1), 10–17 (1987). https://doi.org/10.2165/00003495-198700331-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198700331-00004